Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2466519rdf:typepubmed:Citationlld:pubmed
pubmed-article:2466519lifeskim:mentionsumls-concept:C0018792lld:lifeskim
pubmed-article:2466519lifeskim:mentionsumls-concept:C0001471lld:lifeskim
pubmed-article:2466519lifeskim:mentionsumls-concept:C0028127lld:lifeskim
pubmed-article:2466519lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:2466519lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2466519lifeskim:mentionsumls-concept:C0682770lld:lifeskim
pubmed-article:2466519lifeskim:mentionsumls-concept:C0004855lld:lifeskim
pubmed-article:2466519pubmed:issue2lld:pubmed
pubmed-article:2466519pubmed:dateCreated1989-5-5lld:pubmed
pubmed-article:2466519pubmed:abstractText1. (-)-N6-phenylisopropyladenosine (R-PIA) and N6-cyclohexyladenosine (CHA), highly selective agonists at A1-adenosine receptors, 5'-N-ethyl-carboxamidoadenosine (NECA), a non-selective agonist at A1 and A2 receptors, and 2-phenylaminoadenosine (CV-1808), a selective A2 agonist, were compared in spontaneously beating and electrically driven atria. R-PIA, CHA and NECA inhibited contraction in both preparations. CV-1808 was not effective up to 500 nM. 2. 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX), a new selective A1 receptor antagonist, competitively inhibited the effects of the adenosine agonists, at low concentrations (IC50 less than 1 nM). 3. CHA and NECA were able to inhibit the positive inotropic effect of Bay K 8644 both in spontaneously beating and in electrically driven atria. 4. R-PIA, CHA and NECA (agonists), 8-phenyltheophylline (PT) and DPCPX (antagonists), failed to influence [3H]-nitrendipine binding on microsomal membranes from guinea-pig atria and ventricles in a range of concentrations from 1 nM to 100 microM. 5. The data support the existence of A1 receptors in atrial tissue. No evidence for a direct interaction between adenosine analogues and Bay K 8644 was found at the level of slow calcium channels. Adenosine analogues appear to antagonize the effects of Bay K 8644 indirectly by activation of A1 receptors.lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:languageenglld:pubmed
pubmed-article:2466519pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:citationSubsetIMlld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2466519pubmed:statusMEDLINElld:pubmed
pubmed-article:2466519pubmed:monthFeblld:pubmed
pubmed-article:2466519pubmed:issn0007-1188lld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:PandolfoLLlld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:FassinaGGlld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:CaparrottaLLlld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:BoreaP APAlld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:RagazziEElld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:FroldiGGlld:pubmed
pubmed-article:2466519pubmed:authorpubmed-author:De BiasiMMlld:pubmed
pubmed-article:2466519pubmed:issnTypePrintlld:pubmed
pubmed-article:2466519pubmed:volume96lld:pubmed
pubmed-article:2466519pubmed:ownerNLMlld:pubmed
pubmed-article:2466519pubmed:authorsCompleteYlld:pubmed
pubmed-article:2466519pubmed:pagination372-8lld:pubmed
pubmed-article:2466519pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:meshHeadingpubmed-meshheading:2466519-...lld:pubmed
pubmed-article:2466519pubmed:year1989lld:pubmed
pubmed-article:2466519pubmed:articleTitleEffect of selective agonists and antagonists on atrial adenosine receptors and their interaction with Bay K 8644 and [3H]-nitrendipine.lld:pubmed
pubmed-article:2466519pubmed:affiliationDepartment of Pharmacology, Padua University, Italy.lld:pubmed
pubmed-article:2466519pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2466519pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2466519pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2466519lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2466519lld:pubmed